BCW Index Drops Along with Broader Stock Market | GenomeWeb
The BCW Index fell 1.9 percent for the five-day trading period ended Tuesday, mirroring a drop in the broader stock market. For the tracking period, the Dow Jones Industrial Average fell 1.5 percent, the Nasdaq declined 1.6 percent, and the Nasdaq Biotech Index dropped 2.6 percent.
 
Fourteen of the 15 companies in the Index lost value, with Qiagen and Bruker BioSciences both falling 4 percent to lead decliners for the week. Stratagene was the only firm to gain ground, closing up 2.6 percent for the week.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: metagenomic-based technique for determining protein structure, and more.

An academic laments the rise of narcissism in the sciences, the Guardian reports.

Outgoing FDA commissioner Robert Califf writes in an editorial that the agency can help boost innovation.

The Trump transition team has asked NIH Director Francis Collins to remain at his post, though it's unclear for how long that will be.